![Foto de José Luis](/img/nophoto.png)
José Luis
Martín Ventura
Publikationen, an denen er mitarbeitet José Luis Martín Ventura (8)
2023
-
B- and T-lymphocyte attenuator could be a new player in accelerated atherosclerosis associated with chronic kidney disease
Clinical science (London, England : 1979), Vol. 137, Núm. 17, pp. 1409-1429
2022
2020
-
Complement C5 Protein as a Marker of Subclinical Atherosclerosis
Journal of the American College of Cardiology, Vol. 75, Núm. 16, pp. 1926-1941
2018
-
Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease
Atherosclerosis, Vol. 270, pp. 13-20
2017
-
Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease
Atherosclerosis, Vol. 260, pp. 130-137
2016
-
Soluble TWEAK and major adverse cardiovascular events in patients with CKD
Clinical Journal of the American Society of Nephrology, Vol. 11, Núm. 3, pp. 413-422
2015
-
Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases
Atherosclerosis, Vol. 239, Núm. 2, pp. 358-363
2013
-
Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease
Journal of Nephrology, Vol. 26, Núm. 6, pp. 1105-1113